Shareholder Votes

NAVIENT CORP shareholders approved Election of 6 directors to hold office until the 2026 Annual Meeting of Shareholders and until their successors have been duly elected or appointed. at the 2026-06-04 meeting.

“The Company’s shareholders elected the following 6 directors to hold office until the 2026 Annual Meeting of Shareholders and until their successors have been duly elected or appointed: For Against Abstain Broker Non-Votes Frederick Arnold 77,332,537 2,106,762 236,963 7,560,654 Edward J. Bramson 77,892,680 1,539,840 243,742 7,560,654 Anna Escobedo Cabral 77,596,632 1,843,978 235,652 7,560,654 Larry A. Klane 74,867,296 4,571,774 237,192 7,560,654 Michael A. Lawson 77,008,298 2,424,725 243,239 7,560,654 David L. Yowan 78,173,784 1,266,180 236,298 7,560,654”

Allied Gaming & Entertainment Inc. shareholders approved Reverse Stock Split Proposal at the 2026-06-01 meeting.

“The stockholders voted to approve an amendment to the Company’s Amended and Restated Certificate of Incorporation, as amended, to effect a reverse stock split of the Company’s common stock, par value $0.0001 per share (“ Common Stock ”), at a ratio in the range of 1-for-2 to 1-for-25, with such ratio to be determined in the discretion of the Board of Directors of the Company (the “ Board ”) and with such reverse stock split to be effected at such time and date, if at all, as determined by the Board in its sole discretion (the “ Reverse Stock Split Proposal ”).”

Cibus, Inc. shareholders approved Ratification of BDO USA, P.C. as independent registered public accounting firm for 2026 at the 2026-06-02 meeting.

“To ratify the appointment by the Audit Committee of BDO USA, P.C. as our independent registered public accounting firm for the year ending December 31, 2026.”

Cibus, Inc. shareholders approved Advisory approval of Named Executive Officer compensation at the 2026-06-02 meeting.

“To approve, on an advisory basis, the compensation of the Company’s Named Executive Officers.”

Cibus, Inc. shareholders approved Election of nine directors to the Board of Directors at the 2026-06-02 meeting.

“To elect nine directors to our Board of Directors”

Pursuit Attractions & Hospitality, Inc. shareholders approved Advisory Approval of Named Executive Officer Compensation at the 2026-06-04 meeting.

“Proposal 3: Advisory Approval of Named Executive Officer Compensation. The Company’s shareholders approved, on an advisory basis, the Company’s named executive officer compensation, based on the following voting results: For Against Abstain Broker Non-Votes 24,563,120 410,711 8,265 960,964”

Pursuit Attractions & Hospitality, Inc. shareholders approved Ratification of the Company’s Independent Registered Public Accounting Firm for 2026 at the 2026-06-04 meeting.

“Proposal 2: Ratification of the Company’s Independent Registered Public Accounting Firm for 2026. The Company’s shareholders ratified the selection of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the 2026 fiscal year, based on the following voting results: For Against Abstain 25,760,199 177,604 5,257”

Pursuit Attractions & Hospitality, Inc. shareholders approved Election of Directors at the 2026-06-04 meeting.

“Proposal 1: Election of Directors. The Company’s shareholders reelected the Class I director nominees to serve until the 2029 annual meeting of the stockholders of the Company in an uncontested election, based on the following voting results: Nominee For Against Abstain Broker Non-Votes Joshua E. Schechter 23,728,863 1,249,380 3,853 960,964 Jill H. Bright 19,854,228 5,125,039 2,829 960,964”

Boxlight Corp shareholders approved Approve the Future Issuance of Shares of the Company’s Class A Common Stock and/or Securities Convertible Into or Exercisable for our Class A Common Stock Equal to 20% or More of our Class A Common Stock Outstanding in a Non-Public Transaction or Series of Transactions at the 2026-06-02 meeting.

“4. Approve the Future Issuance of Shares of the Company’s Class A Common Stock and/or Securities Convertible Into or Exercisable for our Class A Common Stock Equal to 20% or More of our Class A Common Stock Outstanding in a Non-Public Transaction or Series of Transactions. The Company’s shareholders voted to approve, as required by Nasdaq Marketplace Listing Rule 5635(d), to authorize the potential issuance of shares of its Class A Common Stock and/or securities convertible into or exercisable for Class A Common Stock in an amount equal to 20% or more of its outstanding Class A Common Stock in connection with a non-public transaction or series of transactions, with the final vote on the matter being reflected as follows: For Against Abstain Broker Non-Votes 1,007,829 125,082 56,051 -”

Boxlight Corp shareholders approved Ratification of the Company’s Independent Auditors at the 2026-06-02 meeting.

“2. Ratification of the Company’s Independent Auditors. The Company’s shareholders voted to ratify the appointment of Cherry Bekaert LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026, with the final vote on the matter being reflected as follows: For Against Abstain Broker Non-Votes 1,903,057 44,063 7,194 -”

Boxlight Corp shareholders approved Election of five director nominees at the 2026-06-02 meeting.

“1. Election of Directors. The Company’s shareholders elected each of the five director nominees set forth below to serve on the Company’s board of directors until the Company’s 2027 annual meeting of shareholders and until their successor have been duly elected and have qualified, with the final vote on the matter being reflected as follows: Nominee For Withheld Broker Non-Votes Michael Pope 1,144,084 44,881 765,349 Carine Clark 1,132,812 56,153 765,349 Peter Fittin 1,132,822 56,143 765,349 Tiffany Kuo 1,126,529 62,436 765,349 Mark Elliott 1,157,199 31,766 765,249”

PMV Pharmaceuticals, Inc. shareholders approved Ratification of Independent Registered Public Accounting Firm at the 2026-06-04 meeting.

“The Company’s stockholders ratified the selection by the Audit Committee of the Company’s Board of Directors of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.”

PMV Pharmaceuticals, Inc. shareholders approved Non-Binding Advisory Vote to Approve the Compensation of the Company’s Named Executive Officers at the 2026-06-04 meeting.

“The Company’s stockholders approved, on a non-binding advisory basis, the compensation paid to its named executive officers as described in the Company’s definitive proxy statement on Schedule 14A, filed with the U.S. Securities and Exchange Commission (the “SEC”) on April 22, 2026 (the “Proxy Statement”).”

PMV Pharmaceuticals, Inc. shareholders approved Election of Directors at the 2026-06-04 meeting.

“The Company’s stockholders elected the two persons listed below as Class III Directors, each to serve until the Company’s 2029 annual meeting of stockholders and until their respective successors has been duly elected and qualified, or until the earlier of the respective director’s death, resignation or removal.”

Sinclair, Inc. shareholders approved A Non-Binding Advisory Vote on Our Executive Compensation at the 2026-06-04 meeting.

“Proposal 3: A Non-Binding Advisory Vote on Our Executive Compensation In response to Proposal 3 as set forth in the Proxy Statement, the stockholders approved, on a non-binding advisory basis, the compensation of the Company’s named executive officers as disclosed in the Compensation Discussion and Analysis and the accompanying tables in the Proxy Statement. The table below sets forth the results of the voting for Proposal 3: For Against Abstain Broker Non-Votes 252,180,048 6,673,805 57,836 6,132,156”

Sinclair, Inc. shareholders approved Ratification of Independent Registered Public Accounting Firm at the 2026-06-04 meeting.

“Proposal 2: Ratification of Independent Registered Public Accounting Firm In response to Proposal 2 as set forth in the Proxy Statement, the stockholders ratified the appointment of PricewaterhouseCoopers LLP as the Company’s independent auditors for the fiscal year ending December 31, 2026. The table below sets forth the results of the voting for Proposal 2: For Against Abstain Broker Non-Votes 264,590,910 412,936 39,999 —”

Sinclair, Inc. shareholders approved Election of Nine Directors at the 2026-06-04 meeting.

“Proposal 1: Election of Nine Directors In response to Proposal 1 as set forth in the Proxy Statement, the stockholders elected all persons nominated to the board of directors of the Company, for a term expiring at the next annual meeting of stockholders in 2027 or until their respective successors have been elected and qualified. The table below sets forth the results of the voting for nominated directors: Election of Directors For Against or Withheld Broker Non-Votes David D. Smith 255,063,410 3,848,279 6,132,156 Frederick G. Smith 255,079,678 3,832,011 6,132,156 J. Duncan Smith 255,079,319 3,832,370 6,132,156 Robert E. Smith 252,762,144 6,149,545 6,132,156 Laurie R. Beyer 257,349,912 1,561,777 6,132,156 Benjamin S. Carson, Sr. 257,176,293 1,735,396 6,132,156 Howard E. Friedman 250,945,578 7,966,111 6,132,156 Daniel C. Keith 254,247,119 4,664,570 6,132,156 Benson E. Legg 254,876,053 4,035,636 6,132,156”

MBX Biosciences, Inc. shareholders approved Ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. at the 2026-06-04 meeting.

“The Company's stockholders approved Proposal 2 to ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. The votes cast at the Annual Meeting were as follows: For Against Abstain Broker Non-Votes 43,713,693 1,946 1,946 -”

MBX Biosciences, Inc. shareholders approved Election of two Class II directors to serve for a three-year term ending at the annual meeting of stockholders to be held in 2029. at the 2026-06-04 meeting.

“The Company's stockholders voted on the following matters, which are described in detail in the Proxy Statement: (i) to elect two Class II director nominees, Patrick J. Heron. and Edward T. Mathers, to the Company's Board of Directors, each to hold office until the Company's 2029 annual meeting of stockholders and until their successors are duly elected and qualified, subject to their earlier death, resignation or removal ("Proposal 1") and (ii) to ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 ("Proposal 2").”

FTI CONSULTING, INC shareholders approved Vote on an advisory (non-binding) resolution to approve the compensation of the named executive officers for the year ended December 31, 2025 as described in the Proxy Statement at the 2026-06-03 meeting.

“Proposal No. 3 - Vote on an advisory (non-binding) resolution to approve the compensation of the named executive officers for the year ended December 31, 2025 as described in the Proxy Statement: For Against Abstentions Broker Non-Votes 26,766,491 183,399 24,400 1,081,462”

FTI CONSULTING, INC shareholders approved Ratify the appointment of KPMG LLP as FTI Consulting, Inc.’s independent registered public accounting firm for the year ending December 31, 2026 at the 2026-06-03 meeting.

“Proposal No. 2 - Ratify the appointment of KPMG LLP as FTI Consulting, Inc.’s independent registered public accounting firm for the year ending December 31, 2026: For Against Abstentions 27,752,240 270,790 32,721”

FTI CONSULTING, INC shareholders approved Elect as directors the eight nominees named in the Proxy Statement at the 2026-06-03 meeting.

“Proposal No. 1 - Elect as directors the eight nominees named in the Proxy Statement: For Against Abstentions Broker Non-Votes Elsy Boglioli 26,481,448 471,325 21,516 1,081,462 Claudio Costamagna 26,347,820 606,235 20,234 1,081,462 Nicholas C. Fanandakis 26,659,958 282,427 31,905 1,081,462 Steven H. Gunby 26,538,764 400,899 34,626 1,081,462 Stephen C. Robinson 26,406,555 548,269 19,465 1,081,462 Laureen E. Seeger 26,442,407 510,392 21,490 1,081,462 Eric T. Steigerwalt 26,918,897 37,918 17,474 1,081,462 Janet H. Zelenka 26,487,306 465,467 21,516 1,081,462”

Zumiez Inc shareholders approved Ratification of appointment of Baker Tilly US, LLP as independent registered public accounting firm at the 2027-01-30 meeting.

“Proposal Number Three: Shareholders ratified the appointment of Baker Tilly US, LLP as the Company’s independent registered public accounting firm for the fiscal year ending January 30, 2027. The results of the vote were as follows: For Against Abstain 14,315,725 104,744 56,617”

Zumiez Inc shareholders approved Advisory vote on executive compensation.

“Proposal Number Two: Shareholders approved an advisory, non-binding, vote on executive compensation. The results of the vote were as follows: For Against Abstain Broker Non-Votes 13,819,292 144,510 65,113 448,171”

Zumiez Inc shareholders approved Election of three directors to serve three-year terms.

“Proposal Number One: Shareholders elected Thomas D. Campion, Liliana Gil Valletta and Carmen R. Bauza as directors to each serve a three-year term until the 2029 Annual Meeting of Shareholders. The results of the vote were as follows: Nominee For Against Abstain Broker Non-Votes Thomas D. Campion 13,486,121 495,840 46,954 448,171 Liliana Gil Valletta 13,509,217 114,716 404,982 448,171 Carmen R. Bauza 13,571,083 398,850 58,982 448,171”

Trane Technologies plc shareholders approved Approval of the determination of the price range at which the Company can reallot shares that it holds as treasury shares.

“Approved the determination of the price range at which the Company can reallot shares that it holds as treasury shares”

Trane Technologies plc shareholders approved Approval of the Directors’ Authority to Issue Shares for Cash.

“Approved the renewal of the Directors’ existing authority to issue shares for cash without first offering shares to existing shareholders”

Trane Technologies plc shareholders approved Approval of the Directors’ Existing Authority to Issue Shares.

“Approved the renewal of the Directors’ existing authority to issue shares”

Trane Technologies plc shareholders approved Approval of the appointment of PricewaterhouseCoopers to serve as the Company’s independent auditors for the fiscal year ending December 31, 2026, and authorized the Audit Committee to set the auditors’ remuneration at the 2026-12-31 meeting.

“Approved the appointment of PricewaterhouseCoopers to serve as the Company’s independent auditors for the fiscal year ending December 31, 2026, and authorized the Audit Committee to set the auditors’ remuneration”

Trane Technologies plc shareholders approved Advisory approval of the compensation of the Company’s named executive officers.

“Provided advisory approval of the compensation of the Company’s named executive officers”

Trane Technologies plc shareholders approved Election of eleven directors.

“Elected all eleven of the Company’s nominees for director”

Seadrill Ltd shareholders approved Approval of Amendment No. 1 to the Amended and Restated Seadrill Limited 2022 Management Incentive Plan at the 2026-06-03 meeting.

“Proposal 6: Approval of Amendment No. 1 to the Amended and Restated Seadrill Limited 2022 Management Incentive Plan Amendment No. 1 to the Amended and Restated Seadrill Limited 2022 Management Incentive Plan was approved, with the vote totals as set forth in the table below: For Against Abstentions Broker Non-Votes 41,146,428 2,201,541 1,547,913 3,956,408”

Seadrill Ltd shareholders approved Advisory vote to approve compensation of named executive officers for 2025 at the 2026-06-03 meeting.

“Proposal 5: Advisory Vote to Approve the Compensation of the Company’s Named Executive Officers The advisory vote to approve the compensation of the Company’s named executive officers for 2025 was approved, with the vote totals as set forth in the table below: For Against Abstentions Broker Non-Votes 41,033,521 2,310,244 1,552,117 3,956,408”

Seadrill Ltd shareholders approved Approval and Ratification of the Remuneration of Directors at the 2026-06-03 meeting.

“Proposal 4: Approval and Ratification of the Remuneration of Directors The remuneration of the directors described in the Proxy Statement was approved and ratified, with the vote totals as set forth in the table below: For Against Abstentions Broker Non-Votes 43,328,331 15,251 1,552,300 3,956,408”

Seadrill Ltd shareholders approved Appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm at the 2026-06-03 meeting.

“Proposal 3: Appointment of the Independent Registered Public Accounting Firm The appointment of PricewaterhouseCoopers LLP, United States (“PwC US”), to serve as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 and until the close of the Company’s next annual general meeting of shareholders thereafter and the authorization of the Board (acting through the Audit and Risk Committee of the Board) to determine the remuneration of PwC US was approved, with the vote totals as set forth in the table below: For Against Abstentions Broker Non-Votes 47,223,781 79,918 1,548,591 —”

Seadrill Ltd shareholders approved Re-election of Directors at the 2026-06-03 meeting.

“Proposal 2: Re-Election of Directors The following director nominees were re-elected as directors of the Company to serve until the Company’s next annual general meeting of shareholders or until their respective offices are otherwise vacated in accordance with the Bye-laws, with the vote totals as set forth in the table below:”

Seadrill Ltd shareholders approved Determine number of directors at up to nine at the 2026-06-03 meeting.

“was approved, with the vote totals as set forth in the table below: For Against Abstentions Broker Non-Votes 43,175,908 173,864 1,546,110 3,956,408”

LEMAITRE VASCULAR INC shareholders approved Ratification of the appointment of Grant Thornton LLP as the Company's independent registered public accounting firm for 2026 at the 2026-06-02 meeting.

“the stockholders ratified the selection of Grant Thornton LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026 with a vote of 21,220,412 shares for and 108,474 shares against, with 7,415 shares abstaining.”

LEMAITRE VASCULAR INC shareholders approved Advisory vote on the compensation of the Company's named executive officers at the 2026-06-02 meeting.

“the stockholders approved, on an advisory basis, the Company's executive compensation by a vote of 19,311,813 shares for and 813,052 shares against, with 13,559 shares abstaining and 1,197,877 broker non-votes.”

LEMAITRE VASCULAR INC shareholders approved Election of two Class II directors at the 2026-06-02 meeting.

“David B. Roberts received a vote of 18,888,412 shares for, 1,250,012 shares withheld and 1,197,877 broker non-votes. John A. Roush received a vote of 14,229,071 shares for, 5,909,353 shares withheld and 1,197,877 broker non-votes.”

Scholar Rock Holding Corp shareholders approved Approval of the Compensation of the Company’s Named Executive Officers on a Non-Binding, Advisory Basis at the 2026-06-04 meeting.

“The stockholders approved, on a non-binding, advisory basis, the compensation of the Company’s named executive officers.”

Scholar Rock Holding Corp shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2026-06-04 meeting.

“The stockholders ratified the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.”

Scholar Rock Holding Corp shareholders approved Election of Class II directors at the 2026-06-04 meeting.

“The stockholders elected each of the persons named below to serve as a Class II director of the Company for a three-year term that expires at the Company’s annual meeting of stockholders in 2029 and until their successors, if any, are duly elected and qualified, subject to their earlier death, resignation or removal.”

ORMAT TECHNOLOGIES, INC. shareholders approved Ratification of Appointment of Kesselman & Kesselman for 2025 at the 2026-12-31 meeting.

“Proposal 3 – Ratification of Appointment of Kesselman & Kesselman for 2025. The stockholders ratified the appointment of Kesselman & Kesselman, a member of PricewaterhouseCoopers International Limited, as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. Votes For Votes Against Votes Abstained 51,202,458 92,147 83,935”

ORMAT TECHNOLOGIES, INC. shareholders approved Approval of the Compensation of our Named Executive Officers on an Advisory Basis.

“Proposal 2 – Approval of the Compensation of our Named Executive Officers on an Advisory Basis The stockholders approved, in a non-binding, advisory vote, the compensation paid to the Company’s named executive officers. Votes For Votes Against Votes Abstained Broker Non-Votes 47,012,094 3,103,710 55,778 1,206,958”

ORMAT TECHNOLOGIES, INC. shareholders approved Election of Directors.

“Proposal 1 - Election of Directors The stockholders elected the following eight individuals to the Board to serve as directors until the 2027 annual meeting of stockholders and until their successors have been duly elected and qualified or until the earlier of their death, resignation, retirement, disqualification or removal from office: Votes For Votes Against Votes Abstained Broker Non-Votes Isaac Angel 48,787,627 1,364,629 19,326 1,206,958 Ravit Barniv 49,900,416 251,992 19,174 1,206,958 Karin Corfee 49,796,002 357,102 18,478 1,206,958 David Granot 48,767,280 1,385,638 18,664 1,206,958 Michal Marom 47,481,759 2,670,000 19,823 1,206,958 Dafna Sharir 48,635,863 1,510,070 25,649 1,206,958 Stanley B. Stern 48,713,601 1,439,644 18,337 1,206,958 Byron G. Wong 49,896,718 255,572 19,292 1,206,958”

Gossamer Bio, Inc. shareholders approved Advisory approval of the compensation of the Company's named executive officers.

“The compensation of the named executive officers was approved, on an advisory basis, by the votes indicated: For Against Abstain Broker Non-Votes 111,286,550 7,545,502 137,461 45,450,098”

Gossamer Bio, Inc. shareholders approved Ratification of the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.

“The selection was ratified by the votes indicated: For Against Abstain Broker Non-Votes 163,185,993 1,192,448 41,170 —”

Gossamer Bio, Inc. shareholders approved Election of two Class II directors for a three-year term to expire at the 2029 annual meeting.

“The following two Class II directors were re-elected by the votes indicated: For Withheld Broker Non-Votes Faheem Hasnain 92,301,637 26,667,876 45,450,098 Russell Cox 88,975,980 29,993,533 45,450,098”

FRESH DEL MONTE PRODUCE INC shareholders approved Approval of Third Amended and Restated Memorandum and Articles of Association at the 2026-06-04 meeting.

“The shareholders approved, by a non-binding, advisory vote, the Third Amended and Restated Memorandum and Articles of Association. For Against Abstain Broker Non-Votes 44,684,417 17,806 74,054 —”